近日，极光旗下人工智能平台Gptbots.AI宣布与Echosens中国建立合作伙伴关系，双方将共同致力于提升无创肝病诊断领域的服务效率与质量。此次合作旨在通过先进的人工智能技术优化诊断流程，为医疗行业提供更精准、高效的支持。
Gptbots.AI将借助其智能算法助力Echosens中国完善肝病筛查方案，减少传统诊断中的时间成本与人为误差。这一举措有望推动非侵入式肝检测技术的标准化与普及，为患者带来更便捷、可靠的医疗体验。
近日，极光旗下人工智能平台Gptbots.AI宣布与Echosens中国建立合作伙伴关系，双方将共同致力于提升无创肝病诊断领域的服务效率与质量。此次合作旨在通过先进的人工智能技术优化诊断流程，为医疗行业提供更精准、高效的支持。
Gptbots.AI将借助其智能算法助力Echosens中国完善肝病筛查方案，减少传统诊断中的时间成本与人为误差。这一举措有望推动非侵入式肝检测技术的标准化与普及，为患者带来更便捷、可靠的医疗体验。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.